Interestingly, the KLA pro-apoptotic peptides guided by either NLN (NLN-KLA) or NEW (NEW-KLA) inhibited tumor growth as well as metastasis in the 4T1 spontaneous tumor metastasis model more efficiently than the combined treatment of each peptide and crizotinib did. The gene discussed is KL; the disease is neoplasm.